ArticleDrug design, development and therapy2024

Comprehensive Assessment of PCSK9 Inhibitors for Lipid Management: Scientific Guidance Based on Drug Selection Recommendations for Chinese Medical Institutions.

Jiabao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.